JP2025504447A5 - - Google Patents
Info
- Publication number
- JP2025504447A5 JP2025504447A5 JP2024542395A JP2024542395A JP2025504447A5 JP 2025504447 A5 JP2025504447 A5 JP 2025504447A5 JP 2024542395 A JP2024542395 A JP 2024542395A JP 2024542395 A JP2024542395 A JP 2024542395A JP 2025504447 A5 JP2025504447 A5 JP 2025504447A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- acid
- pharmaceutical composition
- cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/072270 | 2022-01-17 | ||
| CN2022072270 | 2022-01-17 | ||
| PCT/CN2023/071973 WO2023134732A1 (en) | 2022-01-17 | 2023-01-12 | Prevention or treatment of cardiovascular diseases with high penetration prodrugs of aspirin and other nsaids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504447A JP2025504447A (ja) | 2025-02-12 |
| JP2025504447A5 true JP2025504447A5 (enExample) | 2026-02-17 |
Family
ID=87280122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024542395A Pending JP2025504447A (ja) | 2022-01-17 | 2023-01-12 | アスピリン及びその他のｎｓａｉｄの高透過プロドラッグによる心血管疾患の予防又は治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250099491A1 (enExample) |
| EP (1) | EP4465993A4 (enExample) |
| JP (1) | JP2025504447A (enExample) |
| KR (1) | KR20250005055A (enExample) |
| CN (1) | CN118632699A (enExample) |
| AU (1) | AU2023206720A1 (enExample) |
| CA (1) | CA3252370A1 (enExample) |
| IL (1) | IL314290A (enExample) |
| TW (1) | TW202339711A (enExample) |
| WO (1) | WO2023134732A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118373749A (zh) * | 2024-04-29 | 2024-07-23 | 四川施成收生态科技有限公司 | 一种含有2-羟基苯甲酸-2-（二乙氨基）乙酯结构的化合物制备及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH399486A (fr) * | 1962-10-02 | 1965-09-30 | Biosedra Lab | Procédé de préparation de nouvelles salicylamides |
| CA2656858C (en) * | 2006-07-09 | 2016-01-19 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of acetylsalicylic acid |
| CN101500983B (zh) * | 2006-07-26 | 2015-09-16 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药 |
| CN111012914A (zh) * | 2012-01-18 | 2020-04-17 | 苏州泰飞尔医药有限公司 | 治疗肺部疾病的高穿透力前药组合物和医药组合物 |
| CN112521305B (zh) * | 2013-03-15 | 2023-04-25 | 苏州泰飞尔医药有限公司 | 治疗帕金森疾病的新型高穿透力药物及其药物组合物 |
-
2023
- 2023-01-12 AU AU2023206720A patent/AU2023206720A1/en active Pending
- 2023-01-12 JP JP2024542395A patent/JP2025504447A/ja active Pending
- 2023-01-12 CA CA3252370A patent/CA3252370A1/en active Pending
- 2023-01-12 KR KR1020247027368A patent/KR20250005055A/ko active Pending
- 2023-01-12 US US18/729,497 patent/US20250099491A1/en active Pending
- 2023-01-12 CN CN202380017401.5A patent/CN118632699A/zh active Pending
- 2023-01-12 IL IL314290A patent/IL314290A/en unknown
- 2023-01-12 WO PCT/CN2023/071973 patent/WO2023134732A1/en not_active Ceased
- 2023-01-12 EP EP23740073.4A patent/EP4465993A4/en active Pending
- 2023-01-16 TW TW112101788A patent/TW202339711A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3259271B1 (en) | Fluorinated derivatives of 3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid and uses thereof | |
| DE60219595T2 (de) | Verfahren zur behandlung von erkrankungen mit malonyl coa-decarboxylase-inhibitoren | |
| US20090023712A1 (en) | Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin | |
| CA2921386A1 (en) | Methods of treating and preventing renal disease using bardoxolone methyl or analogs thereof | |
| MXPA04001153A (es) | Derivados de amidina para tratar la amiloidosis. | |
| SG172981A1 (en) | Methods for treating acute myocardial infarctions and associated disorders | |
| JP2022539329A5 (enExample) | ||
| AU2014340182A1 (en) | Cromolyn derivatives and related methods of imaging and treatment | |
| JP2016514141A5 (enExample) | ||
| JP2025504447A5 (enExample) | ||
| KR20230093341A (ko) | 폐고혈압을 치료하기 위한 병용 요법 | |
| AU2021288679A1 (en) | Methods for treating or preventing chronic kidney disease | |
| ES2349471T3 (es) | Derivados de azabiciclooctan-3-ona y su uso. | |
| JPH06504277A (ja) | 新規な３，４−ジヒドロイソキノリン誘導体並びに炭素環式及び複素環式の縮合ジヒドロピリジンの新規な医薬としての使用 | |
| CN100395236C (zh) | 用于治疗神经病的哌嗪和哌啶衍生物 | |
| JP4658919B2 (ja) | フェニルカルボン酸アミドおよびＩＫｒチャンネル遮断剤の組み合わせならびに心房性不整脈を処置するためのその使用 | |
| RU2005122323A (ru) | Производные бензамида в качестве агонистов окситоцина и антагонистов вазопрессина | |
| WO2022076881A1 (en) | Methods of treating alzheimer's disease using slow tight binding soluble epoxide hydrolase inhibitors | |
| ES2671732T3 (es) | Procedimiento mejorado para preparar un compuesto intermedio del inhibidor de proteasa macrocíclico TMC 435 | |
| JPH04217656A (ja) | ３−メチルチオプロピオニル−ｌ−カルニチンおよび医薬組成物 | |
| WO2019070709A1 (en) | COMPOUNDS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | |
| SK6842000A3 (en) | A mixture of inhibitors, a combined pharmaceutical composition comprising the same and use thereof | |
| CN117143040B (zh) | 一种环丁烯二酮基苯并恶唑衍生物及其制备方法和应用 | |
| US20130217778A1 (en) | Methods and compositions for the improvement of skeletal muscle function in a mammal | |
| US20260014170A1 (en) | Prodrugs for delivery of testosterone to the central nervous system |